Series A - MediSieve
Investment Firm
Overview
MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Announced Date
Jun 04, 2018
Funding Type
Series A
Highlights
Location
Europe
Social
Participant Investors
2
| Investor Name |
|---|
 24 Haymarket |
Round Details and Background
MediSieve raised $2330298 on 2018-06-04 in Series A
MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Company Funding History
10
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 30, 2019 |  Grant - MediSieve | 3 | - | 2.0M |
| Jun 23, 2021 | Venture Round - MediSieve | 1 | - | 2.5M |
| Jun 23, 2021 | Grant - MediSieve | 1 | - | 2.2M |
| Mar 07, 2016 | Non Equity Assistance - MediSieve | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.